Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Daré Bioscience, Inc. DARE

Full chart Compare
Set alert

Price alert · DARE

All alert types
0.62 USD -0.02 (-3.50%)

At closeNov 5, 2026, 4:00 PM EST

0.61 -0.01 -2.07%

After hours · Nov 5, 4:00 PM ET

0.61 Day range 0.6799
0.61 52-week range 3.78
YTD
-67.67%
1 year
-66.09%

Financial health

Altman Z-Score

-13.48 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 5
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -1.6×
FY 2016: -2.8×FY 2017: -7.3×FY 2018: -0.3×FY 2019: -0.9×FY 2020: -1.5×FY 2021: -3.2×FY 2022: -2.3×FY 2023: -0.9×FY 2024: -6.5×FY 2025: -1.6×
FY 2016 5y median -2.3× FY 2025
P/S 209×
FY 2016: 145×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 7.0×FY 2023: 9.6×FY 2024: 2710×FY 2025: 209×
FY 2016 5y median 9.6× FY 2025
P/B 75.9×
FY 2016: 8.5×FY 2017: 0.5×FY 2018: 1.1×FY 2019: 29.0×FY 2020: -35.0×FY 2021: 3.2×FY 2022: 6.3×FY 2023: -5.3×FY 2024: -4.4×FY 2025: 75.9×
FY 2016 5y median 3.2× FY 2025
P/FCF -21.0×
FY 2016: -3.3×FY 2017: -2.8×FY 2018: -0.7×FY 2019: -1.0×FY 2020: -1.6×FY 2021: -4.2×FY 2022: -3.9×FY 2023: -0.7×FY 2024: 5.5×FY 2025: -21.0×
FY 2016 5y median -3.9× FY 2025
EV/EBITDA -18.6×
FY 2016: -2.4×FY 2017: 0.1×FY 2018: -0.1×FY 2019: -0.6×FY 2020: -1.3×FY 2021: -1.8×FY 2022: -1.2×FY 2023: -0.6×FY 2024: -3.0×FY 2025: -18.6×
FY 2016 5y median -1.8× FY 2025
EV/Sales 188×
FY 2016: 116×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 3.6×FY 2023: 6.4×FY 2024: 1238×FY 2025: 188×
FY 2016 5y median 6.4× FY 2025
FCF Yield -4.8%
FY 2016: -30.6%FY 2017: -36.3%FY 2018: -134.8%FY 2019: -104.3%FY 2020: -62.6%FY 2021: -23.5%FY 2022: -25.9%FY 2023: -146.3%FY 2024: 18.2%FY 2025: -4.8%
FY 2016 5y median -23.5% FY 2025

Profitability

Gross Margin -137.5%
FY 2016: 47.8%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -201.4%FY 2023: -670.6%FY 2024: -146110.2%FY 2025: -137.5%
FY 2016 5y median -201.4% FY 2025
Operating Margin -1315.5%
FY 2016: -4850.4%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -313.9%FY 2023: -1101.9%FY 2024: -239692.2%FY 2025: -1315.5%
FY 2016 5y median -1101.9% FY 2025
Net Margin -1300.7%
FY 2016: -5131.2%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -309.5%FY 2023: -1074.2%FY 2024: -41430.9%FY 2025: -1300.7%
FY 2016 5y median -1074.2% FY 2025
ROE -471.4%
FY 2016: -299.8%FY 2017: -86.5%FY 2018: -248.8%FY 2019: -3235.7%FY 2020: 2379.1%FY 2021: -99.8%FY 2022: -278.5%FY 2023: 597.5%FY 2024: 67.4%FY 2025: -471.4%
FY 2016 5y median -99.8% FY 2025
ROIC -124.5%
FY 2016: -127.5%FY 2017: -84.1%FY 2018: -250.6%FY 2019: -640.0%FY 2020: -4528.5%FY 2021: -97.6%FY 2022: -249.1%FY 2023: -2435.2%FY 2024: -2253.3%FY 2025: -124.5%
FY 2016 5y median -249.1% FY 2025
ROA -41.3%
FY 2016: -104.3%FY 2017: -80.7%FY 2018: -213.9%FY 2019: -191.6%FY 2020: -362.9%FY 2021: -69.3%FY 2022: -70.6%FY 2023: -141.7%FY 2024: -18.3%FY 2025: -41.3%
FY 2016 5y median -69.3% FY 2025

Growth (YoY)

Revenue 10429.4%
FY 2016: 0.0%FY 2017: -100.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: -71.9%FY 2024: -99.7%FY 2025: 10429.4%
FY 2016 FY 2025
Operating Income 42.2%
FY 2016: 0.0%FY 2017: 69.9%FY 2018: -51.0%FY 2019: 15.0%FY 2020: -91.0%FY 2021: -42.6%FY 2022: 19.7%FY 2023: 1.4%FY 2024: 24.2%FY 2025: 42.2%
FY 2016 FY 2025
EPS (diluted) -150.0%
FY 2016: -92.8%FY 2017: 88.1%FY 2018: -747.2%FY 2019: 63.6%FY 2020: 0.5%FY 2021: 31.2%FY 2022: 41.6%FY 2023: 5.5%FY 2024: 88.4%FY 2025: -150.0%
FY 2016 FY 2025
Free Cash Flow -313.0%
FY 2016: -5.8%FY 2017: 92.5%FY 2018: -304.7%FY 2019: -29.5%FY 2020: -89.6%FY 2021: -14.0%FY 2022: 36.9%FY 2023: -117.5%FY 2024: 112.2%FY 2025: -313.0%
FY 2016 FY 2025

Financial Health

Current Ratio 1.1×
FY 2016: 2.2×FY 2017: 8.6×FY 2018: 6.6×FY 2019: 1.1×FY 2020: 0.9×FY 2021: 3.4×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 0.9×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Quick Ratio 1.1×
FY 2016: 2.3×FY 2017: 8.3×FY 2018: 376×FY 2019: 1.1×FY 2020: 0.9×FY 2021: 3.4×FY 2022: 1.4×FY 2023: 0.9×FY 2024: 0.9×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
Debt / Equity 0.9×
FY 2016: 1.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 1.8×FY 2020: -0.7×FY 2021: 0.0×FY 2022: 0.0×FY 2023: -0.3×FY 2024: -0.2×FY 2025: 0.9×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA 2.1×
FY 2016: 0.6×FY 2017: 0.9×FY 2018: 0.6×FY 2019: 0.3×FY 2020: 0.1×FY 2021: 1.3×FY 2022: 1.1×FY 2023: 0.3×FY 2024: 3.6×FY 2025: 2.1×
FY 2016 5y median 1.3× FY 2025
Interest Coverage -16.5×
FY 2016: -16.6×FY 2017: -34.7×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -16.5×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31